Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Police: Aurora gunman likely knew he was being fired

Feb 16, 2019

AURORA, Ill. — The man who gunned down five co-workers and wounded a sixth at a suburban Chicago manufacturing warehouse before shooting and wounding five police officers brought his gun to a meeting in which he was going to be fired, authorities said Saturday. Because Gary Martin brought his gun to Friday's meeting at the sprawling Henry Pratt Co. warehouse in Aurora, he likely knew he might be about to lose the job he had held for 15 years, police Chief Kristen Ziman said at a news conference. Ziman said she didn't know what had been conveyed to Martin, why...

Tear gas, hate speech marks 14th yellow vest protest

Feb 16, 2019

PARIS — Police fired tear gas and brought in water cannons and a horse brigade to disperse several thousand yellow vest protesters Saturday massed near a Paris landmark at the end of a march through the French capital, the 14th straight weekend of demonstrations. Anti-Semitic remarks hurled by a few at a noted philosopher on the protesters' route were the bitter finale to a day of tension. Acrid clouds of tear gas filled the esplanade of Les Invalides monument, obscuring the gold dome that crowns the monument housing Napoleon's tomb. Tension also marked demonstrations in other cities. In Rouen, in...

The Latest: Aurora victim started internship day he died

Feb 16, 2019

AURORA, Ill. — The Latest on the mass shooting at a warehouse in Aurora, Illinois (all times local): 2:15 p.m. One of the five people who were killed by a fired worker at a suburban Chicago industrial warehouse was a 21-year-old college student who had started interning there that day. Jay Wehner says his nephew, Trevor Wehner, began his human resources internship at the Henry Pratt Co. in Aurora on Friday. Authorities say a 45-year-old worker pulled a gun after being fired and fatally shot Wehner and four other employees. They say he wounded a sixth employee and five police...

NBA, FIBA announce plans for pro league in Africa

Feb 16, 2019

CHARLOTTE, N.C. — The NBA is bringing a pro league to Africa. The Basketball Africa League, a new collaboration between the NBA and the sport's global governing body FIBA, was announced Saturday. The initial plan is for the 12-team league to begin play in January, and former President Barack Obama is among those who are expected to have direct involvement with the league's operations. It's yet to be determined which existing club teams will be part of the league. Qualification tournaments will be held later this year to determine those clubs, with teams from Angola, Egypt, Kenya, Morocco, Nigeria, Rwanda,...

The Latest: NBA, FIBA bringing pro league to Africa

Feb 16, 2019

CHARLOTTE, N.C. — The Latest on NBA All-Star Weekend (all times local): 12:50 p.m. The NBA is bringing a pro league to Africa. The Basketball Africa League, a collaboration between the NBA and the sport's global governing body FIBA, was announced Saturday. The initial plan is for the 12-team league to begin play in January. It's yet to be determined which existing club teams will be part of the league. Qualification tournaments will be held later this year to determine those clubs, with teams from Angola, Egypt, Kenya, Morocco, Nigeria, Rwanda, Senegal, South Africa and Tunisia expected to be among...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com